Agilon Health Inc ( (AGL) ) has released its Q4 earnings. Here is a breakdown of the information Agilon Health Inc presented to its investors.
Agilon Health Inc. is a healthcare company that partners with physicians to transform healthcare delivery through a value-based Total Care Model, focusing on senior patients. In its latest earnings report for the fourth quarter and fiscal year 2024, Agilon Health reported a significant revenue increase of 44% to $1.52 billion in the fourth quarter and a 40% increase to $6.06 billion for the full year, driven by substantial growth in Medicare Advantage membership. The company’s Medicare Advantage membership rose by 36% to 527,000, contributing to a total platform membership of 659,000 by the end of 2024.
The financial results highlighted a notable improvement in net losses, with a reduction to $106 million in the fourth quarter from $230 million in the previous year. The adjusted EBITDA loss also showed improvement, decreasing to $84 million from $137 million in the fourth quarter of 2023. Despite these improvements, the company faced challenges with a negative gross profit of $38 million in the fourth quarter, although this was an improvement from the previous year’s negative $95 million.
Agilon Health’s strategic actions, including reducing underwriting risks and enhancing platform capabilities, have laid a stronger foundation for future success. The company anticipates adding approximately 20,000 new Medicare Advantage members in 2025, despite the challenging Medicare Advantage environment. The management remains focused on supporting physician partners to deliver high-quality, cost-effective care while driving long-term sustainable financial performance.
Looking ahead, Agilon Health’s guidance for 2025 reflects continued membership growth and strategic market exits, with expectations of elevated medical cost trends. The company aims to enhance clinical and operating programs, improve physician onboarding, and manage clinical expenses effectively. Agilon Health’s management remains optimistic about the company’s ability to navigate the challenging environment and achieve sustainable growth.